Estrogens were found to exert a biphasic effect on the density of serotoninl receptors in the female rat brain: an acute reduction in serotonin receptor density throughout the brain is followed 48 to 72 hr later by a selective increase in those brain regions known to contain estrogen receptorshypothalamus, preoptic area, and amygdala. The acute reduction in serotonin receptor density can be mimicked by estradiol in vitro. We conclude that estradiol may have a fast, direct effect on brain membranes to modify serotonin receptor availability, while exerting a slow effect on the same receptors through an interaction with intracellular estrogen receptors in those brain regions that contain them. The observation that female sex hormones are involved in the regulation of serotoninr receptors may have important implications in the understanding of female sexual behavior in the female rat and in the understanding of hormone-linked emotional disturbances in women.
Female gonadal hormones have been shown to affect serotonin neurotransmission in several ways. The turnover and levels of brain serotonin change during the estrous cycle of the rat (Fludder and Tonge, 1975) , during pregnancy, or following injection of ovarian sex steroids (Greengrass and Tonge, 1974) . E&radio1 and progesterone treatment modifies serotonin uptake in the hypothalamus (Endersby and Wilson, 1974) and other brain regions (Wirz-Justice et al., 1974) . We have found that female rats are more sensitive than males to an elevation of brain serotonin, responding to lower doses of pargyline plus tryptophan (Biegon et al., 1979) . Such a sex difference could be due to hormonal modulation of postsynaptic receptor affinity or density. A subsequent study showed that serotonin receptor density does indeed fluctuate in the basal forebrain during the estrous cycle of the rat (Biegon et al., 1980) , resulting in a 50% lower density on proestrus than on diestrus.
Two questions raised by these results are: which hormone or hormones play a part in the modulation of serotonin receptors during the estrous cycle and through which mechanism or mechanisms are these effects ex- ' ' To whom correspondence should be addressed.
erted? Estradiol has been shown to affect several receptor systems in both the periphery and the brain (Roberts et al., 1978; MacLusky and McEwen, 1978; Rainbow et al., 1980a) . Therefore, the present study was designed to test the effect of estradiol on serotoninr receptors in the brains of ovariectomized female rats in vivo and in vitro and to investigate the possible involvement of progesterone and pituitary hormones.
Materials and Methods Sprague-Dawley female rats (150 to 200 gm, Charles River) were kept under standard light (14:lO 1ight:dark cycle) and temperature (22.8"C) conditions. Food and water were available ad libitum. Bilateral ovariectomy was performed under ether anesthesia. Animals were allowed at least 7 days to recover. Hypophysectomized rats were purchased from Charles River and used 7 days after surgery.
Hormone treatment Experiment 1. Pairs of ovariectomized females were injected with estradiol (Ez) in 50% ethanol/saline, S.C. Control animals were injected with the same volume (100 d) of vehicle. One hour later, the animals were sacrificed by decapitation and the brains were removed quickly and dissected on ice using the method outlined by Luine et al. (1974) . Estradiol doses were 2, 5, 10, 20, 50, and 100 pg/animal. Experiment 2. Estradiol benzoate (EB) in sesame oil was injected subcutaneously and the .animals were decapitated 2 hr later. Control animals received only vehicle 200 Biegon and McEwen Vol. 2, No. 2, Feb. 1982 (100 d). EB was given in doses of 2, 5, 10, and 25 pg/ animal. Experiment 3. Groups of six to eight animals were injected with 10 pg/animal of EB in oil at 0 and 24 hr and decapitated at 72 hr. In some cases, progesterone, 2.5 mg, was given 3 hr before sacrifice. Two groups of hypophysectomized animals were included in this experiment in order to establish the role of the pituitary in the response to estrogen treatment. The possible involvement of prolactin was investigated in animals implanted with ectopic pituitaries under the kidney capsule. Under these circumstances, the ectopic pituitary is believed to secrete high levels of prolactin (e.g., McNeilly et al., 1980) . Experiment 4. Several steroid hormones (final concentration, 10-l" to lop4 M) were added directly to the assay tubes containing the labeled serotonin. All were dissolved in 10 ~1 of ethanol.
Experiment 5. A lop4 M solution of EB in ethanol was diluted by a buffer containing 50 mu Tris-HCl and 3.5% polyvinylpyrrolidone (PVP), pH 7.6, to a final concentration of lo-' M. Tissue from whole forebrain or cortex was preincubated in this steroid-containing buffer for 2 hr at room temperature prior to the receptor binding assay. Control tissue was incubated with Tris buffer alone or with Tris/PVP buffer.
Serotonin binding assay
The assay procedure is based on the method of Bennett and Snyder (1976) as modified by Nelson et al. (1978) . For experiments 1 and 2, fresh tissue (weighed) was homogenized in an isotonic Tris-Na+-K' buffer, pH 7.25, in a glass-Teflon homogenizer. The homogenate was centrifuged at 1,000 x g for 10 min. The pellet was washed by an additional portion of buffer and centrifuged again. The combined supernatant fractions (S,) were homogenized by a Polytron (setting 7) and incubated for 10 min at 37°C to facilitate destruction of endogenous serotonin by endogenous monoamine oxidase. After the addition of 100 PM pargyline, aliquots from this fraction were added to the assay tubes. Alternatively, the S1 fraction was spun down at 30,000 x g for 10 min, and the pellet was resuspended in 50 mM Tris-HCl buffer and incubated for 10 min at 37°C prior to the final resuspension in 100 PM pargyline and 0.02% ascorbate buffer and addition to the assay tubes.
Assay tubes contained 0.2 ml of the appropriate concentration of ["Hlserotonin (New England Nuclear, 30 .2 Ci/mmol; 0.3 to 5 nM), 0.5 ml of brain homogenate (100 to 500 pg/sample), and 0.3 ml of Tris/pargyline/ascorbate buffer, with or without lop6 M cold serotonin for estimating nonspecific binding. Tissue was incubated with the ligand for 10 min at 37°C and then transferred to an ice water bath and filtered through Whatman GF/ B glass fiber filters using a Brandel cell harvester (Gaithersburg, MD). Filtration was followed by three 2-set washes with ice cold buffer, 2 set apart. This was found to be equivalent to 15 ml of wash buffer under the conditions of our assay. Filters were placed in plastic vials containing 5 ml of Liquiscint (National Diagnostics) scintillation fluid, incubated for 10 min at 5O"C, and then cooled and counted in a Packard 3255 liquid scintillation counter at 33% efficiency.
For experiments 3 and 4, frozen crude membrane preparations were made up in isotonic buffer and kept at -70°C until used. Thawed membranes were washed in 50 mM Tris-HCl buffer, pH 7.6, and then processed in the same way as fresh membranes. In experiment 5, the 2-hr incubation at room temperature was taken to substitute for the lo-min incubation at 37°C and was followed by centrifugation at 30,000 x g for 10 min, resuspension in Tris/pargyline/ascorbate buffer, etc. Protein content was determined by the method of Bradford (1976) .
Results
Validation of the binding assay. The characteristics of serotonin, binding, in terms of B,,, and &, are similar to those reported in the literature by us and others (Biegon et al., 1980; Nelson et al., 1978; Bennett and Snyder, 1976) , with K,I being 1 to 6 nM and B,,, ranging from 200 to 1,000 fmol/mg of protein, depending on the brain region involved. The pharmacological specificity was validated through displacement experiments with several drugs. Using 2 nM [3H]serotonin (5-HT) and several concentrations of each displacer, the following K, values were obtained: lysergic acid diethylamide, 8.5 f 1 nM; 5-HT, 3.5 f 1 nM; methyltryptamine, 500 nM; mianserin, 1,000 f 200 nM; haloperidol, 2,500 nM; spiroperidol, 7,500 nM; pimozide, 10,OO nM. These values, too, are in good agreement with the literature.
Acute in vivo treatment. Injection of estradiol in 50% ethanol/saline produces a significant and dose-dependent decrease in serotonin receptor binding. The reduction in serotonin binding appears in both hypothalamic and nonhypothalamic brain regions to the same extent. After observing this in preliminary experiments, we started using the whole forebrain to study the dose-response relationship. This decrease is due to a reduction in the maximal number of binding sites as revealed by Scatchard analysis of the binding data ( Fig. 1) . A trend toward increased affinity (lower &) is also apparent. Even the lowest dose, 2 pg/animal, produces a 35% reduction in B,,,. However, the dose-response curve seems to level off at the higher doses, reaching 70 to 80% inhibition (Fig. 2 ).
An injection of 2 pg of Ez ethanol/saline results in levels of Ez in the circulation higher than those achieved under physiological conditions (Krey et al., 1979) . Also, the presence of alcohol may conceivably complicate the interpretation of the data since alcohol itself may interfere with binding to membranes (e.g., Inaba and Kamata, 1979) . Therefore, we repeated these experiments using estradiol benzoate (EB) dissolved in sesame oil. Under these conditions, a significant decrease in serotonergic binding is apparent following a 5-pg EB dose (Fig. 2) . The effect is dose dependent and a dose of 25 pg of EB inhibits up to 70% of the binding. Thus, it is evident that, independently of solvent and whether it is administered as the free alcohol or as the benzoate ester, estradiol is capable of reducing the concentration of serotonin receptors within 1 to 2 hr of injection.
However, classical receptor induction or the development of subsensitivity usually takes longer than 1 to 2 hr (Nelson et al., 1978; Samanin et al., 1980) . Therefore, we also studied the delayed effects of estradiol in animals sacrificed 72 hr after the first of two lo-pg injections of EB in oil. This paradigm results in an increase in serotonin receptor levels, which is, however, restricted to estrogen-concentrating areas in the brain (e.g., Pfaff and Keiner, 1973) . The increase is due to a selective effect on B Inax, with no significant changes in the affinity ( Fig. 3 ; Table I ). Increases of 30 to 40% occur in the amygdala, mediobasal hypothalamus, and preoptic area. No change is observed in the caudate nucleus or in the cerebral cortex, where the acute effects described above were studied (Table I) . Progesterone (2.5 mg) had no additional effect when injected 3 hr before sacrifice in estrogen-primed rats (data not shown).
Hruska and co-workers (Hruska and Silbergeld, 1980; Hruska et al., 1980) have demonstrated the induction of dopamine receptors in the striatum following treatment with estradiol. In those studies, however, hypophysec- tomy abolished the estradiol-dependent increase and prolactin alone was able to produce such increases in the absence of estrogens. We found that hypophysectomy did not abolish the increase in serotonin receptors in steroid-concentrating areas. Moreover, no increase was observed in ovariectomized animals exposed for 2 weeks to elevated levels of prolactin (Table II) In vitro studies. The decreased binding of serotonin seen 1 or 2 hr after estradiol treatment might be due to either an extremely rapid estrogen receptor-mediated, genomic mechanism or a direct effect on the cell membrane. In an effort to identify the mechanism operative in this case, we studied the effect on serotonin binding of the incubation of membranes with steroids in vitro. The crude membrane preparation used for the binding studies does not contain cytoplasmic estrogen receptors so that any effect that we see is probably independent of those estrogen receptors. Simultaneous incubation of steroids with serotonin has no effect at low concentrations. In and above the micromolar range, serotonin binding is decreased. At 10m4 M, 17/3-estradiol and its metabolite, 2-hydroxy-17P-estradiol, reduce the apparent receptor number by 30 to 40% (Fig.  4) . 17a-Estradiol, the inactive stereoisomer, is less active. Other steroid hormones, such as progesterone, corticosterone, and testosterone, showed no activity at all at concentrations up to 10e4 M. Varying r3H]5-HT concentrations in the presence of 15 mM 2-hydroxyestradiol followed by Scatchard analysis of the binding data reveals a 50% decrease in the B,,, (McEwen et al., 1981) .
Thus, it seems that, even at these high concentrations of steroids, which are unlikely to occur in vivo, the steroids do not compete with serotonin for its receptor (an interaction that would result in an apparent decrease in affinity with no change in B,,,) but rather interact with the membrane in a manner that reduces the number of available binding sites. A possible mechanism has been put forward recently by Heron et al. (1980) . They suggest that, by changing the microviscosity in the membrane, the steroid (in their case, cholesterol) may increase or decrease the apparent number of serotonin receptors by exposing extra receptors or "submerging" them in the Table   III ). This is due to a 20 to 25% decrease in B,,,. The steroid also tends to increase the affinity of the binding relative to the PVP control, which is reminiscent of the size and direction of the effect of low doses of EB in uiuo (Fig. 2) . Estradiol in concentrations of 10-l" M or below had no effect.
Discussion
The present studies reveal a biphasic effect of estradiol on serotonin receptors: i.e., an acute reduction in the receptor concentration is followed by a delayed increase. The reduction in serotonin receptor levels 1 or 2 hr after an estradiol injection is evident throughout the brain of the ovariectomized female rat and is mimicked by a 2-hr preincubation of brain (e.g., cerebral cortex) membranes with low concentrations of estradiol in the presence of Although we observed decreased receptor levels in all brain regions following acute estrogen treatment, these acute effects might very well be restricted to estrogenconcentrating areas in the intact, cycling animal. Goodman (1977 Goodman ( , 1978 has shown that estrogen levels in the hypothalamus of the intact, proestrus female rat are 5-fold higher than in the cortex, which, in turn, has twice terone receptors in the chick oviduct (Tokarz et al., 1978) .
In the brain, receptor induction by estrogen seems to is supported further, in one case, by the fact that proges-' p < 0.02, compared to PVP control.
tin receptor induction is blocked by a protein synthesis inhibitor (Rainbow et al., 1980b) . Therefore, our working hypothesis is that the increase in serotonin binding is PVP as well as by concurrent incubation with high condue to an estrogen receptor-mediated, genomic action of centrations of steroids. the hormone. Obviously, this assumption will have to be The increase in serotonin receptor levels 72 hr after supported by further experiments involving estrogen anestradiol benzoate injection is restricted to estrogen-contagonists and protein synthesis inhibitors. In any event, centrating brain regions (Pfaff and Keiner, 1973) : i.e., a pituitary hormone-mediated action is unlikely, since, mediobasal hypothalamus, amygdala, and preoptic area.
unlike the estrogen-induced increase in striatal dopamine In the cortex or the striatum, there is no effect. This receptors (Hruska et al., 1980) , the increase in serotonin effect can be elicited by EB in hypophysectomized anireceptors is not abolished by hypophysectomy or mimmals and it is not mimicked by pituitary grafts under the icked by pituitary grafts under the kidney capsule. kidney capsule.
Much less is known about the possible mechanism Taken together, these findings may explain the obunderlying the acute reduction in serotonin receptors. A served cyclicity in serotonin receptors in basal forebrain few examples relevant to this effect do exist. Estrogen during the estrous cycle. On proestrus, in the presence of has been shown to decrease luteinizing hormone-releaspeak levels of estrogen, we may expect to see the 20 to ing hormone receptor binding in the pituitary following 25% decrease in serotonin receptor number, such as is both in uiuo and in vitro treatment (Heber and Odell, evident after injecting a low dose of EB or after incuba-1979) and to decrease responsiveness to serotonin in the tion of membranes with nanomolar concentrations of guinea pig ileum preparation (Seaman et al., 1977) . The estradiol. Forty-eight hours later, when the circulating fact that these interactions also occur in vitro in prepalevels of estrogens are low, we might expect to see the rations that presumably do not contain intracellular esdelayed, receptor-mediated effect of estrogen on sero-trogen receptors strongly suggests that a direct interactonin receptors, resulting in a 20 to 30% increase in tion with the membrane is involved. The fact that the receptor number. Thus, the biphasic effect of the horchange is in receptor number but not affinity argues mone may result in a total 40 to 50% difference between against the idea of estradiol competing for the serotonin proestrus and diestrus in brain areas which display both
receptor. An attractive possibility is that estradiol is effects. We are conducting a further analysis of these taken up into the membrane (as has actually been re-204 Biegon and McEwen Vol. 2, No. 2, Feb. 1982 ported for 2-hydroxyestradiol (Schaeffer et al., 1980) ), causing an overall change in the microenvironment of receptors. Serotonin receptors have been found to be very sensitive to this type of manipulation when it was performed using cholesterol, which actually increases serotonin binding (Heron et al., 1980) . The changes in membrane microviscosity and receptor binding reported by these investigators require a long preincubation in the presence of PVP. In our initial in vitro experiments reported in Figure 3 , we utilized concurrent incubation of steroid and ["H]&HT and obtained reductions of binding only with micromolar concentrations of estrogens. Other steroids, like progesterone, were ineffective up to 100 PM. In subsequent in vitro experiments, we utilized a 2-hr preincubation of membranes with steroids in the presence of PVP and we obtained estrogen effects on ["H]&HT binding at nanomolar steroid concentrations. These actions had the same characteristic effect of enhancing the apparent affinity while reducing the B,,, (Fig. 5) as we obtained using concurrent incubation with higher estrogen concentrations (McEwen et al., 1981) . Furthermore, in recent experiments, we have determined that, using preincubation with PVP, progesterone does not decrease ["H]&HT binding even in the micromolar range (A. Biegon, B. S. McEwen, and L. Snyder, unpublished observation).
In contrast to the nanomolar sensitivity of ["H]5-HT binding reported in this study, higher steroid concentrations in the micromolar range have been reported to reduce dopamine and noradrenaline binding to synaptic membranes from rat brain (Inaba and Kamata, 1979) , to block histamine-dependent cyclic AMP production in rat hypothalamus (Portaleone et al., 1980) , and to compete with cy,-adrenergic receptor antagonists in binding to rat cerebral cortex membranes (McEwen et al., 1981) . By introducing longer incubation times and PVP to the aladrenergic receptor assay, we were unable to change the nature or the dose range of the competitive estrogen effect nor did we obtain any estrogen effect upon 5-HT2 receptors under similar conditions (B. S. McEwen, A. Biegon, and L. Snyder, unpublished observation et al., 1975; Van Praag and Korf, 1971) . Estrogen-induced changes in serotonin receptors during the menstrual cycle or pregnancy may contribute to the known emotional liability associated with the premenstrual and postpartum periods (Dalton, 1964 (Dalton, , 1971 . Recent reports of estrogens themselves being efficient antidepressants in drug-resistant female patients (Klaiber et al., 1979) and essential for the expression of antidepressant action in rats (Fludder and Tonge, 1977; Kendall et al., 1981) further support the idea that estrogen modulation of the serotonergic system plays an important role in control of affect in susceptible women (e.g., Warren et al., 1979) .
